Yoshimura Noriko, Iidaka Toshiko, Horii Chiaki, Tanegashima Gaku, Muraki Shigeyuki, Oka Hiroyuki, Kawaguchi Hiroshi, Akune Toru, Nakamura Kozo, Tanaka Sakae
Department of Prevention Medicine for Locomotive Organ Disorders, 22th Century Medical and Research Center, The University of Tokyo, Tokyo, 113-8655, Japan.
Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.
Arch Osteoporos. 2025 Aug 27;20(1):117. doi: 10.1007/s11657-025-01601-9.
We examined the trends in vitamin D insufficiency and deficiency over a 10-year period in the general population. The prevalence of deficiency significantly decreased (29.5% vs. 21.6%), whereas mean serum levels increased (23.3 ng/mL vs. 25.1 ng/mL). These trends may reduce the incidence of osteoporosis and osteoporotic fractures.
We aimed to clarify the trends in the prevalence of vitamin D insufficiency and deficiency in the general population using population-based cohort data from a baseline survey and a follow-up survey conducted 10 years later.
A baseline survey of the Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted from 2005 to 2007. Blood samples were collected to measure serum 25-hydroxyvitamin D (25D) and intact parathyroid hormone levels from 1,683 participants (595 men, 1,088 women). Participants also completed an interviewer-administered questionnaire, and underwent bone mineral density measurements and radiographic examinations. The fourth survey was conducted from 2015 to 2016 with 1,906 individuals (637 men, 1,269 women), including both follow-up participants from the baseline survey and newly recruited individuals to increase the sample size for future longitudinal analyses. All participants completed assessments identical to those in the baseline survey. Vitamin D deficiency and insufficiency were defined as serum 25D levels of < 20 ng/mL and ≥ 20 ng/mL but < 30 ng/mL, respectively.
The mean serum vitamin D levels were 23.3 ng/mL at baseline and 25.1 ng/mL at the fourth survey, indicating a significant increase (p < 0.001). The prevalences of vitamin D insufficiency and deficiency were 52.9% and 29.5%, respectively, at baseline, and 54.8% and 21.6%, respectively, in the fourth survey, indicating a significant decrease in vitamin D deficiency (p < 0.001).
In this population-based survey with a 10-year interval, the prevalence of hypovitaminosis D significantly decreased. This favourable trend may contribute to future reductions in the incidence of osteoporosis and osteoporotic fractures.
我们研究了普通人群中维生素D不足和缺乏情况在10年期间的变化趋势。缺乏的患病率显著下降(29.5%对21.6%),而血清平均水平有所升高(23.3 ng/mL对25.1 ng/mL)。这些趋势可能会降低骨质疏松症和骨质疏松性骨折的发生率。
我们旨在利用基于人群的队列数据,通过基线调查和10年后进行的随访调查,阐明普通人群中维生素D不足和缺乏患病率的变化趋势。
2005年至2007年开展了骨关节炎/骨质疏松症与残疾研究(ROAD)的基线调查。采集了1683名参与者(595名男性,1088名女性)的血样,以测量血清25-羟维生素D(25D)和完整甲状旁腺激素水平。参与者还完成了一份由访员实施的问卷,并接受了骨密度测量和影像学检查。2015年至2016年进行了第四次调查,共有1906人(637名男性,1269名女性),包括基线调查的随访参与者和新招募的个体,以增加样本量用于未来的纵向分析。所有参与者都完成了与基线调查相同的评估。维生素D缺乏和不足分别定义为血清25D水平<20 ng/mL和≥20 ng/mL但<30 ng/mL。
基线时血清维生素D平均水平为23.3 ng/mL,第四次调查时为25.1 ng/mL,显示出显著升高(p<0.001)。基线时维生素D不足和缺乏的患病率分别为52.9%和29.5%,第四次调查时分别为54.8%和21.6%,表明维生素D缺乏显著下降(p<0.001)。
在这项间隔10年的基于人群的调查中,维生素D缺乏症的患病率显著下降。这一有利趋势可能有助于未来降低骨质疏松症和骨质疏松性骨折的发生率。